BIOMAT Database Logo BIOMAT Database Logo

The Proton-Sensing GPR4 Receptor Regulates Paracellular Gap Formation and Permeability of Vascular Endothelial Cells. 2020

Elizabeth A Krewson, and Edward J Sanderlin, and Mona A Marie, and Shayan Nik Akhtar, and Juraj Velcicky, and Pius Loetscher, and Li V Yang
Department of Anatomy and Cell Biology, East Carolina University, Greenville, NC 27834, USA.

GPR4 is a pH-sensing G protein-coupled receptor highly expressed in vascular endothelial cells and can be activated by protons in the inflamed tissue microenvironment. Herein, we report that acidosis-induced GPR4 activation increases paracellular gap formation and permeability of vascular endothelial cells through the Gα12/13/Rho GTPase signaling pathway. Evaluation of GPR4 in the inflammatory response using the acute hindlimb ischemia-reperfusion mouse model revealed that GPR4 mediates tissue edema, inflammatory exudate formation, endothelial adhesion molecule expression, and leukocyte infiltration in the inflamed tissue. Genetic knockout and pharmacologic inhibition of GPR4 alleviate tissue inflammation. These results suggest GPR4 is a pro-inflammatory receptor and could be targeted for therapeutic intervention.

UI MeSH Term Description Entries

Related Publications

Elizabeth A Krewson, and Edward J Sanderlin, and Mona A Marie, and Shayan Nik Akhtar, and Juraj Velcicky, and Pius Loetscher, and Li V Yang
Regulation of endothelial cell gap formation and paracellular permeability.
April 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research,
Elizabeth A Krewson, and Edward J Sanderlin, and Mona A Marie, and Shayan Nik Akhtar, and Juraj Velcicky, and Pius Loetscher, and Li V Yang
Acidosis activation of the proton-sensing GPR4 receptor stimulates vascular endothelial cell inflammatory responses revealed by transcriptome analysis.
January 2013, PloS one,
Elizabeth A Krewson, and Edward J Sanderlin, and Mona A Marie, and Shayan Nik Akhtar, and Juraj Velcicky, and Pius Loetscher, and Li V Yang
Inhibition of tumor cell migration and metastasis by the proton-sensing GPR4 receptor.
December 2011, Cancer letters,
Elizabeth A Krewson, and Edward J Sanderlin, and Mona A Marie, and Shayan Nik Akhtar, and Juraj Velcicky, and Pius Loetscher, and Li V Yang
VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor.
April 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Elizabeth A Krewson, and Edward J Sanderlin, and Mona A Marie, and Shayan Nik Akhtar, and Juraj Velcicky, and Pius Loetscher, and Li V Yang
A novel lysophospholipid- and pH-sensitive receptor, GPR4, in brain endothelial cells regulates monocyte transmigration.
January 2007, Endothelium : journal of endothelial cell research,
Elizabeth A Krewson, and Edward J Sanderlin, and Mona A Marie, and Shayan Nik Akhtar, and Juraj Velcicky, and Pius Loetscher, and Li V Yang
The Proton-Sensing G-Protein Coupled Receptor GPR4 Promotes Angiogenesis in Head and Neck Cancer.
January 2016, PloS one,
Elizabeth A Krewson, and Edward J Sanderlin, and Mona A Marie, and Shayan Nik Akhtar, and Juraj Velcicky, and Pius Loetscher, and Li V Yang
Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor.
December 2011, Angiogenesis,
Elizabeth A Krewson, and Edward J Sanderlin, and Mona A Marie, and Shayan Nik Akhtar, and Juraj Velcicky, and Pius Loetscher, and Li V Yang
The Proton-activated Receptor GPR4 Modulates Intestinal Inflammation.
February 2018, Journal of Crohn's & colitis,
Elizabeth A Krewson, and Edward J Sanderlin, and Mona A Marie, and Shayan Nik Akhtar, and Juraj Velcicky, and Pius Loetscher, and Li V Yang
Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway.
October 2019, EBioMedicine,
Elizabeth A Krewson, and Edward J Sanderlin, and Mona A Marie, and Shayan Nik Akhtar, and Juraj Velcicky, and Pius Loetscher, and Li V Yang
Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression.
November 2004, The Journal of allergy and clinical immunology,
Copied contents to your clipboard!